Search

Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before having a transplant appear to be at higher risk for developing complications. These findings further support evidence that the connection between microbiota and outcomes starts before people begin the transplantation process. These findings were presented as part of the 2018 annual meeting of the American Society of Hematology (ASH) press program.

Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.

A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer.

A new pilot study by investigators at Memorial Sloan Kettering Cancer Center found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.

MSK ranked #15 across all companies and industries in New York State (NYS) and #2 in the NYS Healthcare & Social Industry.

Thanks to MSK’s expertise in treating young people with cancer, 16-year-old high school athlete Sammy is back to doing what he loves.

Some children enjoy playing with blocks, dolls, and toy cars. Dr. Ying Liu, a gynecologic medical oncologist and attending in the Clinical Genetics Service at Memorial Sloan Kettering, was fascinated by the test tubes in her mother’s laboratory. Dr. Liu didn’t know it then, but holding those sleek glass cylinders was the same as looking into a crystal ball.

Kathryn V. Anderson has been elected a member of the Institute of Medicine of the National Academies.